John E Bishop

CIK 1308911 · See Remarks · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.92M

Companies

4

Total Filings

132

Lifetime Open-Market Net

-$6.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX See Remarks 336,845 $5.69 $1.92M -$33.0K 3 2026-05-22
LYRA Chief Technology Officer $0.70 $0 2 2024-02-01
Forma Therapeutics Holdings, Inc. (FMTX) Delisted SVP, Chief Technology Officer 0 $20.01 $0 $0 3 2022-10-14
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Senior VP, Pharmaceutical Scie 157,640 -$6.40M 124 2016-05-23

Recent Filings · Page 7 of 14

132 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-02-21 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed +10,761 -$3.0K EDGAR
2013-02-19 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −970 -$11.9K EDGAR
2012-11-28 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −472 -$5.0K EDGAR
2012-11-21 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −244 -$2.7K EDGAR
2012-08-30 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −2,397 -$34.9K EDGAR
2012-08-30 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −232 -$3.3K EDGAR
2012-08-27 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −238 -$3.2K EDGAR
2012-08-23 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −244 -$3.4K EDGAR
2012-08-13 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −7,485 -$101.6K EDGAR
2012-05-31 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −233 -$3.2K EDGAR
Showing 6170 of 132
Page 7 of 14
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.